International Journal of Clinical Research

Objective To study the clinical efficacy of Nimodipine combined with rosuvastatin calcium tablets in the treatment of hypertensive intracerebral hemorrhage. Methods 100 patients with hypertensive cerebral hemorrhage admitted to our hospital from January 2022 to October 2023 were randomly divided into control group and experimental group, and the application effects of different treatment methods were analyzed. Results The improvement of nerve function, edema volume and hematoma volume in experimental group was better than that in control group, compared with the level of inflammatory factors, the experimental group was better than the control group, P < 0.05. There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion Nimodipine combined with rosuvastatin calcium tablets can improve the clinical symptoms of patients with hypertensive intracerebral hemorrhage, control the development of the disease, make the neurological function of the patients be well regulated, the level of inflammatory factors in the patients is significantly reduced, improve the recovery speed and effect of patients, and improve the quality of life of patients.

Nimodipine; Rosuvastatin calcium tablets; Hypertensive cerebral hemorrhage; Combination therapy; Clinical effect